Heading into the 2026 season, there are question marks about who will be the starting quarterback for the Oregon Ducks. Will ...

It’s been a tough year for makers of prescription digital therapeutics, many of whom have had to drastically cut staff—or even, in the case of Pear Therapeutics, completely shut down—to conserve ...

BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili” or “Company"), a leading prescription digital medicine company developing novel treatments for cognitive dysfunction and brain-related conditions, ...

Akili Interactive, which makes a prescription video game for kids with ADHD, began trading on Monday. It's one of ten healthcare companies to go public in the US this year. The SEC filing reveals four ...

Akili, which made history last summer by earning regulatory clearance for the first video-game based therapy, now plans to test if its software can help adults suffering from Covid “brain fog.” Two ...

Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It's a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved ...

Akili Interactive, the maker of a Food and Drug Administration-cleared video game to treat ADHD, has long been bullish on the tremendous potential of its technology to reach wide swaths of the ...

The team at Akili describes its ethos on its website as “establishing a new era of cognitive medicine.” The company writes it “[believes] effective medicine can also be fun and engaging [by] creating ...

After nearly a decade of work, Akili Interactive received the green light from the FDA to market its video game as a treatment for ADHD. It wasn’t an easy feat, and the company still has a long road ...

Editor's note: The original version of this story claimed that STARS-ADHD Adjunctive enrolled 2016 subjects, instead of 206. We apologize for this error. Digital ...